Author

T. Garfagnini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Friedler· 2 shared G. Mayer· 2 shared E. Van Kappel· 1 shared F. A. Dekker· 1 shared F. Forster· 1 shared H. Jensen· 1 shared J. Aragones Pedrola· 1 shared J. J. Hoozemans· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. Friedler

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

FibrilPaint to determine the length of Tau amyloids in fluids

J. Aragones Pedrola, F. A. Dekker, T. Garfagnini, G. Mayer, M. B. Koopman, M. Bergmeijer, F. Forster, J. J. Hoozemans, H. Jensen, A. Friedler, S. G. Rudiger

FibrilPaint1 measures Tau amyloid fibril length in fluids using fluorescence and microfluidics, enabling diagnostic and research applications in neurodegenerative diseases.

bioRxiv · Oct 13, 2023 · PreprintBiochemistry

A peptide strategy for inhibiting different protein aggregation pathways in disease

T. Garfagnini, L. Ferrari, M. Koopman, S. Halters, E. Van Kappel, G. Mayer, M. Maurice, S. Rudiger, A. Friedler

The paper develops a peptide strategy that inhibits both amorphous and amyloid protein aggregation by targeting early aggregation stages, showing effectiveness against unrelated proteins like Axin and Tau.

bioRxiv · Oct 22, 2022 · PreprintBiochemistry